News of the WeekANTHRAX VACCINE

NIAID's $233 Million Problem Put on Hold

Science  16 May 2003:
Vol. 300, Issue 5622, pp. 1065
DOI: 10.1126/science.300.5622.1065a

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

Two influential U.S. senators have ridden to the rescue of the National Institute of Allergy and Infectious Diseases, which has been scrambling to comply with a surprise directive from the White House Office of Management and Budget to commit $233 million of its fiscal year 2003 budget to "procure" millions of doses of a new-generation anthrax vaccine.

Related Content